Related Experiment Videos
[Interleukin 2 inhibitor activity in blood serum]
H Friemel1, M Nausch, H Werner
1Institut für Immunologie, Bereich Medizin der Wilhelm-Pieck-Universität Rostock.
Allergie Und Immunologie
|January 1, 1987
Summary
Normal sera from various species contain an inhibitor that blocks T cell proliferation by reducing interleukin-2 (IL-2) receptor expression. This immune inhibitor
Area of Science:
- Immunology
- Cell Biology
Background:
- Interleukin-2 (IL-2) is crucial for T cell proliferation.
- Serum components can modulate immune responses.
Purpose of the Study:
- To investigate the inhibitory effects of normal sera on T cell proliferation.
- To characterize the nature of the serum-derived IL-2 inhibitor.
Main Methods:
- In vitro proliferation assays using thymocytes, T blast cells, and cytotoxic T lymphocytes.
- IL-2 binding assays and IL-2 receptor expression analysis.
- Gel filtration and ammonium sulfate precipitation for inhibitor characterization.
Main Results:
- Normal murine, horse, and human sera dose-dependently inhibit IL-2-dependent T cell proliferation.
- The inhibitor reduces IL-2 receptor expression but not IL-2 binding.
- Excess IL-2 can overcome the inhibitory effect.
- The inhibitor has a molecular weight of approximately 80,000 MW and is precipitated by 50% ammonium sulfate.
- Low species-specificity was observed.
Conclusions:
- A novel IL-2 inhibitor present in normal sera plays a role in natural immunoregulation.
- This inhibitor acts by downregulating IL-2 receptor expression, offering insights into immune system activation and control.